University of Sumer   Report issue

Academic/Hospital
Founded: Al-Rifai Iraq (2014)

Organization Overview

First Clinical Trial
2018
NCT03834831
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

University of Sumer | University of Sumer, Iraq

Active Ingredients

Drugs in Other Trials (2)

selenium (1 trial)

ubiquinone (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2